Načítá se...
Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
OBJECTIVE: To estimate the effectiveness and harms of Serenoa repens monotherapy in the treatment of lower urinary tract symptoms (LUTS) consistent with benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), a...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513282/ https://ncbi.nlm.nih.gov/pubmed/22551330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2012.11172.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|